NSC |
Compound |
Enrichment |
Correlation |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.0163859626459254 |
0.33267987 |
NSC 709100 |
Null |
0.0163859626459254 |
0.10427697 |
NSC 709564 |
Null |
0.0163859626459254 |
0.23128172 |
NSC 720199 |
Null |
0.0163859626459254 |
0.19425441 |
NSC 728040 |
2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline |
0.0163859626459254 |
0.22274057 |
NSC 732517 |
Dasatinib |
0.0163859626459254 |
-0.18545997 |
NSC 732698 |
1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne |
0.0163859626459254 |
0.13265283 |
NSC 736153 |
Null |
0.0163859626459254 |
0.3343649 |
NSC 743432 |
2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
0.0163859626459254 |
0.29214791 |
NSC 743556 |
Null |
0.0163859626459254 |
0.20543215 |